ATI N180 Pharmacology Exam | Nurselytic

Questions 60

ATI RN

ATI RN Test Bank

ATI N180 Pharmacology Exam Questions

Extract:


Question 1 of 5

A nurse is caring for a patient who is newly prescribed with celecoxib (Celebrex) Which of the following statements is TRUE regarding celecoxib (Celebrex)?

Correct Answer: A

Rationale: The correct answer is A: This medication inhibits COX-2 receptors only. Celecoxib is a selective COX-2 inhibitor, meaning it specifically targets and inhibits the enzyme cyclooxygenase-2. This selective inhibition reduces inflammation and pain without affecting COX-1, which is responsible for maintaining the stomach lining.

Choices B, C, and D are incorrect because celecoxib does not target mu or kappa receptors; these are opioid receptors involved in pain modulation, not the mechanism of action of celecoxib. Overall, understanding the pharmacological properties of celecoxib as a COX-2 inhibitor is crucial in providing safe and effective patient care.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

Similar Questions

Access More Questions!

ATI RN Basic


$89/ 30 days

 

ATI RN Premium


$150/ 90 days